PROTARA THERAPEUTICS INC's ticker is TARA and the CUSIP is 74365U107. A total of 34 filers reported holding PROTARA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $26,438 | -61.9% | 15,831 | -45.5% | 0.00% | – |
Q2 2023 | $69,432 | +28.0% | 29,051 | +67.6% | 0.00% | – |
Q1 2023 | $54,262 | +117860.9% | 17,336 | 0.0% | 0.00% | – |
Q4 2022 | $46 | -100.0% | 17,336 | -70.3% | 0.00% | -100.0% |
Q3 2022 | $173,000 | +1.2% | 58,389 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $171,000 | -23.7% | 58,389 | +33.5% | 0.00% | 0.0% |
Q1 2022 | $224,000 | – | 43,741 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 2,558,472 | $43,059,000 | 8.42% |
CVI Holdings, LLC | 168,836 | $2,842,000 | 1.16% |
Soleus Capital Management, L.P. | 100,000 | $1,683,000 | 0.89% |
Ikarian Capital, LLC | 722,443 | $12,158,000 | 0.88% |
COWEN AND COMPANY, LLC | 124,171 | $2,090,000 | 0.34% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 782,670 | $13,172,000 | 0.32% |
Cormorant Asset Management, LP | 450,000 | $7,574,000 | 0.29% |
Rock Springs Capital Management LP | 643,622 | $10,832,000 | 0.28% |
Perceptive Advisors | 608,544 | $10,242,000 | 0.15% |
Maven Securities LTD | 100,000 | $1,688,000 | 0.14% |